These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38117656)
1. Protocol for screening α-synuclein PET tracer candidates in vitro and ex vivo. Xiang J; Xia Y; Luo S; Zhang Z; Ye K STAR Protoc; 2024 Mar; 5(1):102788. PubMed ID: 38117656 [TBL] [Abstract][Full Text] [Related]
2. In Silico, in Vitro, and in Vivo Evaluation of New Candidates for α-Synuclein PET Imaging. Verdurand M; Levigoureux E; Zeinyeh W; Berthier L; Mendjel-Herda M; Cadarossanesaib F; Bouillot C; Iecker T; Terreux R; Lancelot S; Chauveau F; Billard T; Zimmer L Mol Pharm; 2018 Aug; 15(8):3153-3166. PubMed ID: 29989823 [TBL] [Abstract][Full Text] [Related]
3. Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies. Xiang J; Tao Y; Xia Y; Luo S; Zhao Q; Li B; Zhang X; Sun Y; Xia W; Zhang M; Kang SS; Ahn EH; Liu X; Xie F; Guan Y; Yang JJ; Bu L; Wu S; Wang X; Cao X; Liu C; Zhang Z; Li D; Ye K Cell; 2023 Aug; 186(16):3350-3367.e19. PubMed ID: 37421950 [TBL] [Abstract][Full Text] [Related]
4. Identification and Evaluation of Bisquinoline Scaffold as a New Candidate for α-Synuclein-PET Imaging. Kaide S; Watanabe H; Shimizu Y; Iikuni S; Nakamoto Y; Hasegawa M; Itoh K; Ono M ACS Chem Neurosci; 2020 Dec; 11(24):4254-4261. PubMed ID: 33258582 [TBL] [Abstract][Full Text] [Related]
10. Development of an α-synuclein fibril and oligomer specific tracer for diagnosis of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. Sevenich M; Honold D; Willuweit A; Kutzsche J; Mohrlüder J; Willbold D Neurochem Int; 2022 Dec; 161():105422. PubMed ID: 36252819 [TBL] [Abstract][Full Text] [Related]
11. Binding of the PET radiotracer [¹⁸F]BF227 does not reflect the presence of alpha-synuclein aggregates in transgenic mice. Levigoureux E; Lancelot S; Bouillot C; Chauveau F; Verdurand M; Verchere J; Billard T; Baron T; Zimmer L Curr Alzheimer Res; 2014; 11(10):955-60. PubMed ID: 25387331 [TBL] [Abstract][Full Text] [Related]
12. Alpha-Synuclein PET Tracer Development-An Overview about Current Efforts. Korat Š; Bidesi NSR; Bonanno F; Di Nanni A; Hoàng ANN; Herfert K; Maurer A; Battisti UM; Bowden GD; Thonon D; Vugts D; Windhorst AD; Herth MM Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577548 [TBL] [Abstract][Full Text] [Related]
13. Toward imaging of alpha-synuclein with PET. Kantarci K Cell; 2023 Aug; 186(16):3327-3329. PubMed ID: 37541192 [TBL] [Abstract][Full Text] [Related]
14. PET imaging in animal models of Parkinson's disease. Ni R Behav Brain Res; 2023 Feb; 438():114174. PubMed ID: 36283568 [TBL] [Abstract][Full Text] [Related]
15. α-synuclein imaging: a critical need for Parkinson's disease research. Eberling JL; Dave KD; Frasier MA J Parkinsons Dis; 2013; 3(4):565-7. PubMed ID: 24192754 [TBL] [Abstract][Full Text] [Related]